Kelley James is currently the Vice President at AstraZeneca, leading the Cardiovascular, Renal, and Metabolic Portfolio with a focus on Life Cycle Management. Their extensive experience in pharmaceutical leadership includes roles such as Global Marketing Director and Franchise Head, contributing to significant strategic initiatives and financial performance in healthcare. Previously, Kelley held various senior positions at GlaxoSmithKline and Gilead Sciences, specializing in oncology, infectious diseases, and market access. Kelley earned a B.Sc. in Physiology from McGill University, complementing a robust background in driving innovation and improving patient care across multiple disease areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices